US3108097A
(en)
|
|
1963-10-22 |
|
Ehnojs |
US2809194A
(en)
|
|
1957-10-08 |
|
Thiadiazine type natriuretic agents |
US488064A
(en)
|
|
1892-12-13 |
|
Magnetic separator |
DE1116676B
(de)
|
1955-03-14 |
1961-11-09 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
|
FR1217929A
(fr)
|
1958-03-03 |
1960-05-06 |
Ciba Geigy |
Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
|
BE578515A
(ru)
|
1958-05-07 |
|
|
|
DE1302648B
(ru)
|
1960-09-27 |
|
|
|
NL281975A
(ru)
|
1961-08-12 |
|
|
|
GB1051218A
(ru)
|
1963-03-09 |
|
|
|
NL127065C
(ru)
|
1964-04-22 |
|
|
|
NL137318C
(ru)
|
1964-06-09 |
|
|
|
GB1078852A
(en)
|
1964-09-30 |
1967-08-09 |
Ici Ltd |
Alkanolamine derivatives
|
US3466325A
(en)
|
1965-04-30 |
1969-09-09 |
Haessle Ab |
1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US3636039A
(en)
|
1970-02-24 |
1972-01-18 |
Hoffmann La Roche |
Substituted benzylimidazolidinones
|
GB1361441A
(en)
|
1970-05-13 |
1974-07-24 |
Sandoz Ltd |
Benzonaphthyridine derivatives
|
US4059622A
(en)
|
1970-05-27 |
1977-11-22 |
Imperial Chemical Industries Limited |
Alkanolamine derivatives
|
GB1338235A
(en)
|
1970-12-15 |
1973-11-21 |
May & Baker Ltd |
Azapurinones
|
DE2117571C3
(de)
|
1971-04-10 |
1979-10-11 |
Bayer Ag, 5090 Leverkusen |
Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
|
BE794964A
(fr)
|
1972-02-04 |
1973-08-02 |
Bristol Myers Co |
Nouveaux agents hypotenseurs et procede pour les preparer
|
JPS5229318B2
(ru)
|
1972-03-30 |
1977-08-01 |
|
|
DE2305339C3
(de)
|
1973-02-03 |
1980-05-08 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
|
US4062950A
(en)
|
1973-09-22 |
1977-12-13 |
Bayer Aktiengesellschaft |
Amino sugar derivatives
|
AR205004A1
(es)
|
1973-10-30 |
1976-03-31 |
Ishikawa M |
Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
|
GB1491510A
(en)
|
1973-12-14 |
1977-11-09 |
Hisamitsu Pharmaceutical Co |
1-nitrophenylquinazoline-2,4(1h,3h)-diones
|
AT334385B
(de)
|
1973-12-20 |
1976-01-10 |
Chemie Linz Ag |
Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
|
DE2402908C2
(de)
|
1974-01-22 |
1982-12-02 |
Fa. Johann A. Wülfing, 4040 Neuss |
7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
|
DE2413935A1
(de)
|
1974-03-20 |
1975-10-16 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone
|
DE2521113A1
(de)
|
1974-05-15 |
1976-03-18 |
Maggioni & C Spa |
Cycloaliphatische derivate von 3.3-diphenylpropylamin
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
US4046889A
(en)
|
1976-02-13 |
1977-09-06 |
E. R. Squibb & Sons, Inc. |
Azetidine-2-carboxylic acid derivatives
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
DE2719912C3
(de)
|
1977-05-04 |
1979-12-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
|
NZ187452A
(en)
|
1977-06-10 |
1980-05-27 |
Otsuka Pharma Co Ltd |
N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
US4466972A
(en)
|
1977-06-20 |
1984-08-21 |
Sandoz Ltd. |
Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
|
NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
CA1114379A
(en)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phthalazines
|
JPS5953920B2
(ja)
|
1977-12-28 |
1984-12-27 |
東洋醸造株式会社 |
新規なアミノ糖化合物およびその製法
|
CA1121290A
(en)
|
1978-02-14 |
1982-04-06 |
Yasuji Suhara |
Amino sugar derivatives
|
JPS54148788A
(en)
|
1978-05-15 |
1979-11-21 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
|
JPS5527105A
(en)
|
1978-08-11 |
1980-02-27 |
Dai Ichi Seiyaku Co Ltd |
Imidazothienopyrimidinones compound
|
US4316906A
(en)
|
1978-08-11 |
1982-02-23 |
E. R. Squibb & Sons, Inc. |
Mercaptoacyl derivatives of substituted prolines
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
JPS5535019A
(en)
|
1978-09-01 |
1980-03-11 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
DE2845220A1
(de)
|
1978-10-17 |
1980-04-30 |
Yoshitomi Pharmaceutical |
Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
|
US4168267A
(en)
|
1978-10-23 |
1979-09-18 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl prolines
|
DE2847693A1
(de)
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
IL58849A
(en)
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
GB2063249A
(en)
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
JPS5671073A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
Imidazole derivative
|
JPS5671074A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
|
IL61501A
(en)
|
1979-11-26 |
1984-06-29 |
Sterling Drug Inc |
5-(pyridinyl)-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
|
DE2951135A1
(de)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
US4344949A
(en)
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
ES505959A0
(es)
|
1980-10-09 |
1982-09-01 |
Hoechst Ag |
Procedimiento para la preparacion de un inactivador de alfa-amilasa
|
JPS5777676A
(en)
|
1980-10-31 |
1982-05-15 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivative
|
US4337201A
(en)
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
EP0056194B1
(en)
|
1981-01-05 |
1984-09-12 |
Takeda Chemical Industries, Ltd. |
N-substituted pseudo-aminosugars, their production and use
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
DE3107100A1
(de)
|
1981-02-20 |
1982-09-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
US4405628A
(en)
|
1981-03-05 |
1983-09-20 |
Merrell Dow Pharmaceuticals Inc. |
4-Pyridylimidazolones and method of use
|
DE3266746D1
(en)
|
1981-03-12 |
1985-11-14 |
Beecham Group Plc |
N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
US4432971A
(en)
|
1981-08-03 |
1984-02-21 |
E. R. Squibb & Sons, Inc. |
Phosphonamidate compounds
|
GB2103614B
(en)
|
1981-08-11 |
1984-11-21 |
Ciba Geigy Ag |
Benzazepin-2-ones
|
HU190412B
(en)
|
1981-09-17 |
1986-09-29 |
Warner-Lambert Co,Us |
Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
|
DE3226768A1
(de)
|
1981-11-05 |
1983-05-26 |
Hoechst Ag, 6230 Frankfurt |
Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
|
EP0080822A1
(en)
|
1981-11-27 |
1983-06-08 |
Beecham Group Plc |
Anti-hypertensive prolinol-based peptides
|
EP0096517A3
(en)
|
1982-06-05 |
1985-04-03 |
Smith Kline & French Laboratories Limited |
Aryl pyrazinones
|
US4452790A
(en)
|
1982-06-23 |
1984-06-05 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4473575A
(en)
|
1982-07-19 |
1984-09-25 |
Ciba-Geigy Corporation |
3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
IL68769A
(en)
|
1983-05-23 |
1986-02-28 |
Hadassah Med Org |
Pharmaceutical compositions containing insulin for oral administration
|
US4503030A
(en)
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
US4722810A
(en)
|
1984-08-16 |
1988-02-02 |
E. R. Squibb & Sons, Inc. |
Enkephalinase inhibitors
|
US4654362A
(en)
|
1983-12-05 |
1987-03-31 |
Janssen Pharmaceutica, N.V. |
Derivatives of 2,2'-iminobisethanol
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
FI844289L
(fi)
|
1984-01-21 |
1985-07-22 |
Hoechst Ag |
Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
|
NL8400924A
(nl)
|
1984-03-23 |
1985-10-16 |
Philips Nv |
Gelijkstroom-wisselstroomomzetter voor het ontsteken en voeden van een gas-en/of dampontladingsbuis.
|
US4849405A
(en)
|
1984-05-09 |
1989-07-18 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
EP0179904A1
(en)
|
1984-05-09 |
1986-05-07 |
Medaphore Inc. |
Oral insulin and a method of making the same
|
US4963526A
(en)
|
1984-05-09 |
1990-10-16 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
PL147842B1
(en)
|
1984-05-12 |
1989-08-31 |
|
Method of obtaining novel pyroisobenzimidazoles
|
ZA853440B
(en)
|
1984-05-14 |
1986-12-30 |
Lilly Co Eli |
Indoline and 2-indolinone derivatives
|
DE3424685A1
(de)
|
1984-07-05 |
1986-02-06 |
Beiersdorf Ag, 2000 Hamburg |
Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
|
US4634765A
(en)
|
1984-12-18 |
1987-01-06 |
Merrell Dow Pharmaceuticals Inc. |
Homodisaccharide hypoglycemic agents
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
JPS61218589A
(ja)
|
1985-03-26 |
1986-09-29 |
Eisai Co Ltd |
5―(6―イミダゾ〔1,2―a〕ピリジニル)ピリジン誘導体
|
US4713244A
(en)
|
1985-08-16 |
1987-12-15 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
|
US4668506A
(en)
|
1985-08-16 |
1987-05-26 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing and amino acid polymer
|
US4931279A
(en)
|
1985-08-16 |
1990-06-05 |
Bausch & Lomb Incorporated |
Sustained release formulation containing an ion-exchange resin
|
ES2031821T3
(es)
|
1985-10-17 |
1993-01-01 |
Smith Kline & French Laboratories Limited |
Procedimiento para preparar derivados de 4(4-oxo-1,4-dihidropiridin-1-il)fenilo.
|
IL77186A0
(en)
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
DE3543999A1
(de)
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
US5036048A
(en)
|
1986-03-07 |
1991-07-30 |
Schering Corporation |
Angiotensin II receptor blockers as antiglaucoma agents
|
WO1987006576A1
(en)
|
1986-04-29 |
1987-11-05 |
Pfizer Inc. |
Calcium independent camp phosphodiesterase inhibitor antidepressant
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US4749688A
(en)
|
1986-06-20 |
1988-06-07 |
Schering Corporation |
Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
US5138069A
(en)
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
DE3779374D1
(en)
|
1986-08-28 |
1992-07-02 |
Sandoz Ag |
Xanthinderivate.
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
GB8630702D0
(en)
|
1986-12-23 |
1987-02-04 |
Wellcome Found |
Quinoline compound
|
WO1988005306A1
(en)
|
1987-01-23 |
1988-07-28 |
The General Hospital Corporation |
Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
|
CA1303037C
(en)
|
1987-02-02 |
1992-06-09 |
Smith Kline & French Laboratories Limited |
Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
US5041152A
(en)
|
1987-03-26 |
1991-08-20 |
Kabushiki Kaisha Toshiba |
Apparatus for bending tubular glass
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
NZ225447A
(en)
|
1987-07-20 |
1991-12-23 |
Merck & Co Inc |
Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
|
SG59988A1
(en)
|
1987-09-04 |
1999-02-22 |
Beecham Group Plc |
Substituted thiazolidinedione derivatives
|
US6288095B1
(en)
|
1987-09-04 |
2001-09-11 |
Beecham Group P.L.C. |
Compounds
|
GB2209937B
(en)
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5192772A
(en)
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
US5015651A
(en)
|
1988-01-07 |
1991-05-14 |
E. I. Du Pont De Nemours And Company |
Treatment of hypertension with 1,2,4-angiotensin II antagonists
|
CA1338238C
(en)
|
1988-01-07 |
1996-04-09 |
David John Carini |
Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
|
US4880804A
(en)
|
1988-01-07 |
1989-11-14 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking benzimidazoles
|
CA1338839C
(en)
|
1988-01-29 |
1997-01-14 |
Yoshio Sasaki |
Controlled release formulation
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
US5142096A
(en)
|
1988-03-31 |
1992-08-25 |
Kyowa Hakko Kogyo Co., Ltd. |
2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds
|
GB8812490D0
(en)
|
1988-05-26 |
1988-06-29 |
Agricultural & Food Res |
Delayed release formulations
|
EP0344383A1
(en)
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Novel alpha-Glucosidase inhibitors
|
JP2792862B2
(ja)
|
1988-07-30 |
1998-09-03 |
寛治 高田 |
経口腸溶製剤
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
US5106834A
(en)
|
1988-12-27 |
1992-04-21 |
G. D. Searle & Co. |
Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
|
US4916129A
(en)
|
1989-01-19 |
1990-04-10 |
E. I. Du Pont De Nemours And Company |
Combination β-blocking/angiotensin II blocking antihypertensives
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
DE3928177A1
(de)
|
1989-04-08 |
1991-02-28 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
WO1990012789A1
(de)
|
1989-04-17 |
1990-11-01 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel
|
EP0400835A1
(en)
|
1989-05-15 |
1990-12-05 |
Merck & Co. Inc. |
Substituted benzimidazoles as angiotensin II antagonists
|
IE64514B1
(en)
|
1989-05-23 |
1995-08-09 |
Zeneca Ltd |
Azaindenes
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
US5157026A
(en)
|
1989-05-30 |
1992-10-20 |
Merck & Co., Inc. |
Oxo-purines as angiotensin II antagonists
|
US5102880A
(en)
|
1989-05-30 |
1992-04-07 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
US5064825A
(en)
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
US5185351A
(en)
|
1989-06-14 |
1993-02-09 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
EP0403158A3
(en)
|
1989-06-14 |
1991-12-18 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids
|
DK0403159T3
(da)
|
1989-06-14 |
2000-08-14 |
Smithkline Beecham Corp |
Imidazolylalkensyrer
|
CA2060656A1
(en)
|
1989-06-30 |
1990-12-31 |
Robert John Ardecky |
Substituted imidazoles
|
WO1991000281A2
(en)
|
1989-06-30 |
1991-01-10 |
E.I. Du Pont De Nemours And Company |
Fused-ring aryl substituted imidazoles
|
US5164407A
(en)
|
1989-07-03 |
1992-11-17 |
Merck & Co., Inc. |
Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
|
CA2020073A1
(en)
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Substituted quinazolinones as angiotensin ii antagonists
|
EP0407342A3
(en)
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
EP0409332A3
(en)
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
DE69024556T2
(de)
|
1989-07-28 |
1996-10-17 |
Merck & Co Inc |
Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten
|
CH679207A5
(ru)
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
DE69013607T2
(de)
|
1989-08-02 |
1995-03-02 |
Takeda Chemical Industries Ltd |
Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
|
AP161A
(en)
|
1989-08-11 |
1991-12-20 |
Ici Plc |
Novel Quinoline derivatives.
|
JP2862576B2
(ja)
|
1989-08-14 |
1999-03-03 |
日産自動車株式会社 |
カチオン電着塗料組成物
|
US5100897A
(en)
|
1989-08-28 |
1992-03-31 |
Merck & Co., Inc. |
Substituted pyrimidinones as angiotensin ii antagonists
|
EP0415886A3
(en)
|
1989-08-30 |
1991-10-23 |
Ciba-Geigy Ag |
Aza compounds
|
IE70593B1
(en)
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
EP0424317A3
(en)
|
1989-10-19 |
1991-09-25 |
Ciba-Geigy Ag |
Pyrimidines
|
IL95975A
(en)
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
AU640417B2
(en)
|
1989-10-25 |
1993-08-26 |
Smithkline Beecham Corporation |
Substituted 5-((tetrazolyl)alkenyl)imidazoles
|
IL96019A0
(en)
|
1989-10-31 |
1991-07-18 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
CA2028925A1
(en)
|
1989-11-06 |
1991-05-07 |
Gerald R. Girard |
Substituted n-(imidazolyl)alkyl alanine derivatives
|
HU215441B
(hu)
|
1989-11-13 |
1999-04-28 |
Pfizer Inc. |
Eljárás az endo-biciklo [2.2.1]-heptan-2-ol előállítására és az ebből kapott hatóanyagok enzimatikus úton történő elválasztására
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
PT95899A
(pt)
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
IE903911A1
(en)
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
US5073566A
(en)
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
EP0430300A3
(en)
|
1989-12-01 |
1992-03-25 |
Takeda Chemical Industries, Ltd. |
Xanthine derivatives, their production and use
|
JPH03223281A
(ja)
|
1989-12-01 |
1991-10-02 |
Glaxo Group Ltd |
ベンゾチオフェン誘導体
|
GB8927277D0
(en)
|
1989-12-01 |
1990-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
US5104891A
(en)
|
1989-12-11 |
1992-04-14 |
G. D. Searle & Co. |
Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
|
DE69032089T2
(de)
|
1989-12-20 |
1998-06-25 |
Texas Instruments Inc |
Kupfer-Aetzverfahren mit Hilfe von Haliden
|
EP0434038A1
(en)
|
1989-12-22 |
1991-06-26 |
Takeda Chemical Industries, Ltd. |
Fused imidazole derivatives, their production and use
|
GB8929208D0
(en)
|
1989-12-27 |
1990-02-28 |
Almirall Lab |
New xanthine derivatives
|
EP0435827A3
(en)
|
1989-12-28 |
1991-11-13 |
Ciba-Geigy Ag |
Diaza compounds
|
CA2032289A1
(en)
|
1989-12-29 |
1991-06-30 |
Joseph A. Finkelstein |
Substituted 5-(alkyl) carboxamide imidazoles
|
JPH05504969A
(ja)
|
1990-02-13 |
1993-07-29 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル要素を含有するアンギオテンシン2アンタゴニスト類
|
EP0515546A4
(en)
|
1990-02-13 |
1993-05-12 |
Merck & Co. Inc. |
Triazole angiotensin ii antagonists incorporating a substituted benzyl element
|
DE69129998T2
(de)
|
1990-02-15 |
1998-12-24 |
Takeda Chemical Industries Ltd |
Pyrimidindionderivate, deren Herstellung und Verwendung
|
DE122010000024I1
(de)
|
1990-02-19 |
2010-07-08 |
Novartis Ag |
Acylverbindungen
|
CA2036618C
(en)
|
1990-02-22 |
2002-10-29 |
Akira Morimoto |
Fused thiophene derivatives, their production and use
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
DE4006693A1
(de)
|
1990-03-01 |
1991-09-05 |
Schering Ag |
Neue benzimidazolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
GB9005354D0
(en)
|
1990-03-09 |
1990-05-02 |
Glaxo Group Ltd |
Chemical compounds
|
US5287273A
(en)
|
1990-03-15 |
1994-02-15 |
Mount Sinai School Of Medicine |
Functional organ images
|
FR2659655B1
(fr)
|
1990-03-19 |
1992-07-24 |
Union Pharma Scient Appl |
Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
US5137906A
(en)
|
1990-03-20 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists
|
TW201738B
(ru)
|
1990-03-20 |
1993-03-11 |
Sanofi Co |
|
US5140037A
(en)
|
1990-03-20 |
1992-08-18 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
|
US5270317A
(en)
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
FR2681067B1
(fr)
|
1991-09-10 |
1993-12-17 |
Elf Sanofi |
Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
US5155126A
(en)
|
1990-03-20 |
1992-10-13 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
|
US5173494A
(en)
|
1990-03-20 |
1992-12-22 |
E. I. Du Pont De Nemours And Company |
Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2
|
US5223516A
(en)
|
1990-03-22 |
1993-06-29 |
E. R. Squibb & Sons, Inc. |
3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same
|
US5063245A
(en)
|
1990-03-28 |
1991-11-05 |
Nova Pharmaceutical Corporation |
Corticotropin-releasing factor antagonism compounds
|
EP0522038A4
(en)
|
1990-03-30 |
1993-05-26 |
Merck & Co. Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
JPH05505822A
(ja)
|
1990-03-30 |
1993-08-26 |
メルク・エンド・カムパニー・インコーポレーテツド |
ピラゾール類、イソキサゾール類及びイソチアゾール置換体
|
DE4010797A1
(de)
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
WO1991015206A1
(en)
|
1990-04-05 |
1991-10-17 |
E.I. Du Pont De Nemours And Company |
Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
|
US5175003A
(en)
|
1990-04-06 |
1992-12-29 |
Biosytes Usa, Inc. |
Dual mechanism controlled release system for drug dosage forms
|
EP0525129A4
(en)
|
1990-04-13 |
1993-03-24 |
Smith-Kline Beecham Corporation |
Substituted benzimidazoles
|
US5196444A
(en)
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
EP0453210A3
(en)
|
1990-04-19 |
1993-01-13 |
Imperial Chemical Industries Plc |
Pyridine derivatives
|
UA27031A1
(ru)
|
1990-04-25 |
2000-02-28 |
Ніссан Кемікал Індастріз Лтд |
ПРОИЗВОДНЫЕ 3(2Н)ПИРИДАЗИНОНА ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ОБЛАДАЮЩИЕ ПРОТИВОТРОБОтическим, ПОЗИТИВНЫМ ИНОТРОПНЫМ, СОСУДОРАСШИРЯЮЩИМ ДЕЙСТВИЕМ И АНТИАЛЛРГИЧЕСКУЮ АКТИВНОСТЬ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
|
US5703110A
(en)
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
US5642868A
(en)
|
1990-05-02 |
1997-07-01 |
The United States Of America As Represented By The Secretary Of The Navy |
Ceramic material
|
IL98087A
(en)
|
1990-05-04 |
1996-11-14 |
Perio Prod Ltd |
Preparation for dispensing drugs in the colon
|
US5098920A
(en)
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
GB9010394D0
(en)
|
1990-05-09 |
1990-06-27 |
Ici Plc |
Heterocyclic compounds
|
MY105344A
(en)
|
1990-05-16 |
1994-09-30 |
Byk Gulden Lomberg Chemische Fabrik |
New sulphonyl compounds
|
WO1991018888A1
(en)
|
1990-05-25 |
1991-12-12 |
G.D. Searle & Co. |
N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
|
US5045540A
(en)
|
1990-05-25 |
1991-09-03 |
Warner-Lambert Co. |
Amino acid derivatives with angiotensin II antagonist properties
|
US5504078A
(en)
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
AU653524B2
(en)
|
1990-06-08 |
1994-10-06 |
Roussel-Uclaf |
New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
|
WO1991019715A1
(en)
|
1990-06-15 |
1991-12-26 |
G.D. Searle & Co. |
1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
CA2051705A1
(en)
|
1990-06-19 |
1991-12-20 |
Kiyoaki Katano |
Pyridine derivatives having angiotensin ii antagonism
|
GB9013750D0
(en)
|
1990-06-20 |
1990-08-08 |
Pfizer Ltd |
Therapeutic agents
|
ATE146076T1
(de)
|
1990-06-22 |
1996-12-15 |
Du Pont |
Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten
|
NZ238688A
(en)
|
1990-06-28 |
1992-05-26 |
Smithkline Beecham Corp |
Substituted histidines: pharmaceutical compositions, preparation and uses thereof
|
IE912114A1
(en)
|
1990-07-02 |
1992-01-15 |
Union Pharma Scient Appl |
Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
|
US5053329A
(en)
|
1990-07-05 |
1991-10-01 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
IL98319A
(en)
|
1990-07-05 |
1997-04-15 |
Roussel Uclaf |
Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
|
HUT65903A
(en)
|
1990-07-10 |
1994-07-28 |
Smithkline Beecham Corp |
Oxamides, process for preparing them and pharmaceutical compositions containing them
|
US5137902A
(en)
|
1990-07-13 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
4-alkylimidazole derivatives and anti-hypertensive use thereof
|
CA2044806A1
(en)
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
US5132216A
(en)
|
1990-07-19 |
1992-07-21 |
Merck & Co., Inc. |
Microbial transformation process for antihypertensive products
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
CA2047029A1
(en)
|
1990-07-19 |
1992-01-20 |
Shieh-Shung T. Chen |
Microbial transformation process for antihypertensive products
|
US5057522A
(en)
|
1990-07-19 |
1991-10-15 |
Merck & Co., Inc. |
Anti-hypersensitive N2-tetrazole-β-glucuronide analog
|
DE4023215A1
(de)
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
NZ239161A
(en)
|
1990-07-31 |
1994-01-26 |
Smithkline Beecham Corp |
Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
GB9017480D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Chemical process
|
GB9017482D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Manufacturing process
|
GB9017479D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Process
|
EP0470543A1
(de)
|
1990-08-10 |
1992-02-12 |
Dr. Karl Thomae GmbH |
Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
|
WO1992002257A2
(en)
|
1990-08-10 |
1992-02-20 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
US5066586A
(en)
|
1990-08-20 |
1991-11-19 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
US5089626A
(en)
|
1990-08-23 |
1992-02-18 |
Merck & Co., Inc. |
Process for preparing an angiotensin II antagonist
|
US5217985A
(en)
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
AU8405691A
(en)
|
1990-09-04 |
1992-03-30 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel tetrahydrobenzazole derivative
|
IE912956A1
(en)
|
1990-09-10 |
1992-03-11 |
Abbott Lab |
Angiotensin ii receptor antagonists
|
IL99372A0
(en)
|
1990-09-10 |
1992-08-18 |
Ciba Geigy Ag |
Azacyclic compounds
|
AU8722291A
(en)
|
1990-09-11 |
1992-03-30 |
Mectra Labs, Inc. |
Disposable lavage
|
US5140036A
(en)
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5210092A
(en)
|
1990-09-25 |
1993-05-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotensin ii antagonizing heterocyclic derivatives
|
US5217877A
(en)
|
1990-09-28 |
1993-06-08 |
Bristol-Myers Squibb Company |
Process for the preparation of α-glucosidase inhibitor, pradimicin Q
|
US5242939A
(en)
|
1990-09-28 |
1993-09-07 |
Warner-Lambert Company |
Anilide derivatives with angiotensin ii antagonist properties
|
US5091418A
(en)
|
1990-09-28 |
1992-02-25 |
Bristol-Myers Squibb Company |
Novel alpha-glucosidase inhibitor, pradimicin Q
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
US5126342A
(en)
|
1990-10-01 |
1992-06-30 |
Merck & Co., Inc. |
Imidazole angiotensin ii antagonists incorporating acidic functional groups
|
JP3208139B2
(ja)
|
1990-10-02 |
2001-09-10 |
ワーナー−ランバート・コンパニー |
アンギオテンシン▲ii▼アンタゴニスト
|
US5260322A
(en)
|
1990-10-08 |
1993-11-09 |
Merck & Co., Inc. |
Angiotension II antagonists in the treatment of hyperuricemia
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US5565473A
(en)
|
1990-10-12 |
1996-10-15 |
Merck Frosst Canada, Inc. |
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
|
CA2053148A1
(en)
|
1990-10-16 |
1992-04-17 |
Karnail Atwal |
Dihydropyrimidine derivatives
|
WO1992006963A1
(de)
|
1990-10-16 |
1992-04-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Arylpyridazinone
|
CA2053340C
(en)
|
1990-10-18 |
2002-04-02 |
Timothy P. Burkholder |
Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
US5130333A
(en)
|
1990-10-19 |
1992-07-14 |
E. R. Squibb & Sons, Inc. |
Method for treating type II diabetes employing a cholesterol lowering drug
|
WO1992007852A1
(en)
|
1990-10-25 |
1992-05-14 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
AU636066B2
(en)
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
PH31175A
(en)
|
1990-10-31 |
1998-03-20 |
Squibb & Sons Inc |
Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
|
US5087634A
(en)
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
DE4036645A1
(de)
|
1990-11-16 |
1992-05-21 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
|
GB9026006D0
(en)
|
1990-11-29 |
1991-01-16 |
Glaxo Group Ltd |
Chemical compounds
|
WO1992009278A1
(en)
|
1990-11-30 |
1992-06-11 |
Smithkline Beecham Corporation |
Substituted 5-aryl imidazoles
|
US5049565A
(en)
|
1990-12-07 |
1991-09-17 |
Merck & Co., Inc. |
Microbial transformation process for preparing anti-hypertensive products
|
CA2057089A1
(en)
|
1990-12-07 |
1992-06-08 |
Eric E. Allen |
Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
|
GB9027197D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027055D0
(en)
|
1990-12-13 |
1991-02-06 |
Sandoz Ltd |
Organic compounds
|
GB9027212D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027210D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027200D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
AU657498B2
(en)
|
1990-12-14 |
1995-03-16 |
Novartis Ag |
Biphenylyl compounds
|
WO1992010097A1
(en)
|
1990-12-14 |
1992-06-25 |
Smithkline Beecham Corporation |
Angiotensin ii receptor blocking compositions
|
GB9027209D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027211D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027199D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027198D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027201D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
GB9027208D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
JPH04234389A
(ja)
|
1990-12-28 |
1992-08-24 |
Sapporo Breweries Ltd |
ナフチリジン誘導体及びそれを有効成分とする抗潰瘍剤
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
CA2058198A1
(en)
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Azole derivatives, process for their preparation, and their use
|
IE914573A1
(en)
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
IE914572A1
(en)
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
IE71647B1
(en)
|
1991-01-28 |
1997-02-26 |
Rhone Poulenc Rorer Ltd |
Benzamide derivatives
|
US5087702A
(en)
|
1991-01-30 |
1992-02-11 |
Merck & Co., Inc. |
Microbial transformation process for producing an antihypertensive product
|
US5124335A
(en)
|
1991-01-30 |
1992-06-23 |
Merck & Co., Inc. |
Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5153347A
(en)
|
1991-01-31 |
1992-10-06 |
E. R. Squibb & Sons, Inc. |
Phosphonate, phosphinate derivatives useful as antihypertensive agents
|
AT395853B
(de)
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
AU1256692A
(en)
|
1991-02-06 |
1992-09-07 |
Schering Corporation |
Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
ATE156120T1
(de)
|
1991-02-07 |
1997-08-15 |
Roussel Uclaf |
Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
IL100555A
(en)
|
1991-02-07 |
2000-08-31 |
Hoechst Marion Roussel Inc |
N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
|
GB9102727D0
(en)
|
1991-02-08 |
1991-03-27 |
Ici Plc |
Pharmaceutical agent
|
IE920175A1
(en)
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
GB9102803D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
GB9102804D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Heterocyclic derivatives
|
IL100917A0
(en)
|
1991-02-16 |
1992-11-15 |
Fisons Plc |
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
|
FR2672892B1
(fr)
|
1991-02-20 |
1994-01-14 |
Synthelabo |
Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
|
FI112942B3
(fi)
|
1991-02-21 |
2012-03-13 |
Daiichi Sankyo Co Ltd |
Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
|
US5104877A
(en)
|
1991-02-25 |
1992-04-14 |
Abbott Laboratories |
Psoriasis treatment
|
CA2061159A1
(en)
|
1991-02-26 |
1992-08-27 |
Michael A. Poss |
Imidazole and benzimidazole derivatives
|
US5187271A
(en)
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
FR2673427B1
(fr)
|
1991-03-01 |
1993-06-18 |
Sanofi Elf |
Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
|
US5202328A
(en)
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
EP0503838A3
(en)
|
1991-03-08 |
1992-10-07 |
Merck & Co. Inc. |
Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
|
US5191086A
(en)
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
EP0505098A1
(en)
|
1991-03-19 |
1992-09-23 |
Merck & Co. Inc. |
Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists
|
US5196537A
(en)
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
US5187179A
(en)
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
HUT64023A
(en)
|
1991-03-22 |
1993-11-29 |
Sandoz Ag |
Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
|
IE73235B1
(en)
|
1991-03-25 |
1997-05-21 |
Akzo Nv |
4-aryl-thiazole or imidazole derivatives
|
US5128327A
(en)
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
EP0505954A1
(en)
|
1991-03-25 |
1992-09-30 |
Glaxo Group Limited |
N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity
|
US5177074A
(en)
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
FR2674849B1
(fr)
|
1991-04-02 |
1994-12-23 |
Logeais Labor Jacques |
Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
|
US5157040A
(en)
|
1991-04-05 |
1992-10-20 |
Merck & Co., Inc. |
Substituted quinolines as angiotensin ii antagonists
|
US5164403A
(en)
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5151435A
(en)
|
1991-04-08 |
1992-09-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating an indole or dihydroindole
|
US5155117A
(en)
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
TW274551B
(ru)
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5190942A
(en)
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
US5449676A
(en)
|
1991-04-26 |
1995-09-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Pyridazines
|
US5252574A
(en)
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
EP0511767A1
(en)
|
1991-04-29 |
1992-11-04 |
Merck & Co. Inc. |
Tablets containing compound DUP753
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
JP3290657B2
(ja)
|
1991-05-01 |
2002-06-10 |
メルク エンド カムパニー インコーポレーテッド |
アンギオテンシンii拮抗剤として活性な酸性アラルキルトリアゾール誘導体
|
US5191084A
(en)
|
1991-05-01 |
1993-03-02 |
American Home Products Corporation |
Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
|
US5162325A
(en)
|
1991-05-07 |
1992-11-10 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
US5198438A
(en)
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
JPH05112533A
(ja)
|
1991-05-08 |
1993-05-07 |
Upjohn Co:The |
イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
US5223501A
(en)
|
1991-05-10 |
1993-06-29 |
Merck & Co., Inc. |
Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
GB9110532D0
(en)
|
1991-05-15 |
1991-07-03 |
Smithkline Beecham Corp |
Chemical compounds
|
NZ242724A
(en)
|
1991-05-15 |
1994-09-27 |
Du Pont |
Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
|
EP0514192A1
(en)
|
1991-05-16 |
1992-11-19 |
Glaxo Group Limited |
Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
|
GB9110636D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
GB9110625D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
MX9202300A
(es)
|
1991-05-16 |
1992-11-01 |
Glaxo Group Ltd |
Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
|
US5292726A
(en)
|
1991-05-22 |
1994-03-08 |
Merck & Co., Inc. |
N,N-diacylpiperazines
|
FR2676734B1
(fr)
|
1991-05-23 |
1995-05-19 |
Roussel Uclaf |
Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
US5175164A
(en)
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な4−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
US5210211A
(en)
|
1991-06-21 |
1993-05-11 |
Warner-Lambert Company |
4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
|
FR2677984B1
(fr)
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
GB9113626D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic compounds
|
GB9113628D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic derivatives
|
IL102183A
(en)
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
|
IL102365A0
(en)
|
1991-07-03 |
1993-01-14 |
Merck & Co Inc |
Substituted triazolinones,their preparation and pharmaceutical compositions containing them
|
FR2678618B1
(fr)
|
1991-07-05 |
1993-11-05 |
Upsa Laboratoires |
Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
DE4123341A1
(de)
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
CH683149A5
(fr)
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5177097A
(en)
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
GB9116039D0
(en)
|
1991-07-25 |
1991-09-11 |
Ucb Sa |
Substituted cyclopropylamino-1,3,5-triazines
|
AU2338992A
(en)
|
1991-07-26 |
1993-03-02 |
G.D. Searle & Co. |
Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders
|
IT1250749B
(it)
|
1991-08-02 |
1995-04-21 |
Luso Farmaco Inst |
Composti eterociclici ad attivita' a ii antagonista
|
AU2390792A
(en)
|
1991-08-05 |
1993-03-02 |
Taisho Pharmaceutical Co., Ltd. |
Thienopyrimidin-4-one derivative
|
US5225401A
(en)
|
1991-08-12 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Treatment of congestive heart failure
|
US5246944A
(en)
|
1991-08-13 |
1993-09-21 |
Merck & Co., Inc. |
Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
|
ATE152718T1
(de)
|
1991-08-15 |
1997-05-15 |
Ciba Geigy Ag |
N-acyl-n-heterocyclyl- oder naphthylalkyl- aminosäuren als angiotensin ii antagonisten
|
CA2115989A1
(en)
|
1991-08-19 |
1993-03-04 |
George Albert Boswell |
Angiotensin ii receptor blocking imidazolinone derivatives
|
JPH06510763A
(ja)
|
1991-08-19 |
1994-12-01 |
イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー |
アンジオテンシン2受容体遮断イミダゾリノン誘導体
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
WO1993005025A1
(en)
|
1991-09-06 |
1993-03-18 |
Glaxo Group Limited |
C-linked pyrazole derivatives
|
DK0531876T3
(ru)
|
1991-09-10 |
1997-02-17 |
Tanabe Seiyaku Co |
|
SG42942A1
(en)
|
1991-09-10 |
1997-10-17 |
Tanabe Seiyaku Co |
Imidazopyridine derivatives and process for preparation thereof
|
TW300219B
(ru)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5256667A
(en)
|
1991-09-25 |
1993-10-26 |
Merck & Co., Inc. |
Quinazolinones and pyridopyrimidinones
|
ZA927211B
(en)
|
1991-09-27 |
1993-03-24 |
Merrell Dow Pharma |
Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
|
ES2106112T3
(es)
|
1991-09-27 |
1997-11-01 |
Merrell Pharma Inc |
Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
|
AU657793B2
(en)
|
1991-09-27 |
1995-03-23 |
Merrell Pharmaceuticals Inc. |
Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
DE4132631A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Imidazolyl-propensaeurederivate
|
DE4132633A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Cyclisch substituierte imidazolyl-propensaeurederivate
|
DE4132632A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Substituierte imidazolyl-propensaeurederivate
|
AT398202B
(de)
|
1991-10-04 |
1994-10-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
CA2079982A1
(en)
|
1991-10-07 |
1993-04-08 |
Stephen E. De Laszlo |
Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
|
US5187159A
(en)
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
ES2135416T3
(es)
|
1991-10-09 |
1999-11-01 |
Syntex Inc |
Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.
|
GB9121463D0
(en)
|
1991-10-10 |
1991-11-27 |
Smithkline Beecham Corp |
Medicament
|
GB9121727D0
(en)
|
1991-10-14 |
1991-11-27 |
Ici Plc |
Heterocyclic compounds
|
US5149699A
(en)
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
US5187168A
(en)
|
1991-10-24 |
1993-02-16 |
American Home Products Corporation |
Substituted quinazolines as angiotensin II antagonists
|
US5234936A
(en)
|
1991-10-24 |
1993-08-10 |
American Home Products Corporation |
Pyrimidocycloalkanes as a ii antagonists
|
US5336677A
(en)
|
1991-10-24 |
1994-08-09 |
American Home Products Corporation |
Substituted aminopyrimidines as antihypertensives
|
TW226375B
(ru)
|
1991-10-24 |
1994-07-11 |
American Home Prod |
|
JPH06107661A
(ja)
|
1991-10-24 |
1994-04-19 |
Upjohn Co:The |
イミダゾール誘導体およびこれを有効成分とする医薬組成物
|
FR2683819B1
(fr)
|
1991-10-28 |
1994-02-11 |
Synthelabo |
Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
|
JP3221894B2
(ja)
|
1991-10-31 |
2001-10-22 |
ダウ・コ−ニング・コ−ポレ−ション |
分岐オルガノポリシロキサンの製造方法
|
US5252753A
(en)
|
1991-11-01 |
1993-10-12 |
Ortho Pharmaceutical Corporation |
Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
US5182288A
(en)
|
1991-11-13 |
1993-01-26 |
Ortho Pharmaceutical Corporation |
Substituted n-biphenylyl lactams
|
EP0543263A3
(en)
|
1991-11-16 |
1993-08-25 |
Dr. Karl Thomae Gmbh |
Benziimidazoles, pharmaceuticals containing them and process for their preparation
|
US5130439A
(en)
|
1991-11-18 |
1992-07-14 |
Lo Young S |
Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
|
AU3237193A
(en)
|
1991-12-11 |
1993-07-19 |
Brigham And Women's Hospital |
S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
|
US5212177A
(en)
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
EP0625162B1
(en)
|
1991-12-30 |
1998-05-13 |
Neurex Corporation |
Methods of producing analgesia and enhancing opiate analgesia
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
WO1993015044A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as tnf and pde iv inhibitors
|
GB9204808D0
(en)
|
1992-03-04 |
1992-04-15 |
Rhone Poulenc Rorer Ltd |
Novel compositions of matter
|
US5208234A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
US5208235A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
US5264437A
(en)
|
1992-03-20 |
1993-11-23 |
Syntex (U.S.A.) Inc. |
Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
|
AU3924993A
(en)
|
1992-04-02 |
1993-11-08 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
EP0634930A4
(en)
|
1992-04-02 |
1995-02-22 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases.
|
JP3199380B2
(ja)
|
1992-04-02 |
2001-08-20 |
スミスクライン・ビーチャム・コーポレイション |
化合物
|
HU225869B1
(en)
|
1992-04-02 |
2007-11-28 |
Smithkline Beecham Corp |
Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
|
US5212195A
(en)
|
1992-05-13 |
1993-05-18 |
Syntex (U.S.A.) Inc. |
Substituted indole antagonists derivatives which are angiotensin II
|
US5552397A
(en)
|
1992-05-18 |
1996-09-03 |
E. R. Squibb & Sons, Inc. |
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
|
DE69325904T2
(de)
|
1992-05-15 |
1999-12-09 |
Merrell Pharma Inc |
MERCAPTOACETYLAMIDE VON PYRIDAZO[1,2-a][1,2]-DIAZEPIN -DERIVATEN ALS EUKEPHALINASE UND ACE-INHIBITOREN
|
RU2124503C1
(ru)
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
GB9211268D0
(en)
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
ES2102036T3
(es)
|
1992-06-15 |
1997-07-16 |
Celltech Therapeutics Ltd |
Derivados con grupo fenilo trisustituido utilizados como inhibidores selectivos de la fosfodiesterasa iv.
|
US5210204A
(en)
|
1992-06-16 |
1993-05-11 |
Warner-Lambert Company |
Biphenyl oxadiazoles and thiadiazoles as angiothesin II antagonists
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
US5969097A
(en)
*
|
1992-06-23 |
1999-10-19 |
G. D. Searle & Co. |
Human guanylin
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
4−アミノキナゾリン誘導体およびそれを含有する医薬品
|
AU4717693A
(en)
|
1992-07-28 |
1994-02-14 |
Rhone-Poulenc Rorer Limited |
Inhibitors of c-amp phosphodiesterase and tnf
|
US5185340A
(en)
|
1992-08-04 |
1993-02-09 |
American Home Products Corporation |
Pyrimidinyl arylalkyl ethers with antihypertensive activity
|
US5741803A
(en)
|
1992-09-05 |
1998-04-21 |
Smithkline Beecham Plc |
Substituted thiazolidinedionle derivatives
|
CA2144510A1
(en)
|
1992-09-14 |
1994-03-31 |
Christian Stief |
Novel use inhibitors of phosphodiestersase iv
|
DK0661989T3
(da)
|
1992-09-21 |
1998-03-02 |
Upjohn Co |
Proteinsammensætninger med vedvarende frigivelse
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
US5504080A
(en)
|
1992-10-28 |
1996-04-02 |
Bristol-Myers Squibb Co. |
Benzo-fused lactams
|
BR9307570A
(pt)
|
1992-12-02 |
1999-05-25 |
Pfizer |
Diéteres de catecol como inibidores seletivos de pdeiv
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
TW263495B
(ru)
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
JP3339730B2
(ja)
|
1992-12-24 |
2002-10-28 |
忠弘 大見 |
半導体装置
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
EP0678018B1
(en)
|
1993-01-06 |
2003-04-09 |
Kinerton Limited |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
US5672659A
(en)
|
1993-01-06 |
1997-09-30 |
Kinerton Limited |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
US5358502A
(en)
|
1993-02-25 |
1994-10-25 |
Pfizer Inc |
PH-triggered osmotic bursting delivery devices
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
EP0688429B1
(en)
*
|
1993-03-09 |
1998-02-11 |
Epic Therapeutics, Inc.. |
Macromolecular microparticles and methods of production
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
US5459151A
(en)
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
GB9309324D0
(en)
|
1993-05-06 |
1993-06-16 |
Bayer Ag |
Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
|
US6191105B1
(en)
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
GB9311282D0
(en)
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
JPH0710875A
(ja)
|
1993-06-21 |
1995-01-13 |
Green Cross Corp:The |
選択的ホスホジエステラーゼiv阻害剤
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
RU2137754C1
(ru)
|
1993-07-02 |
1999-09-20 |
Бик Гульден Ломберг Хемише Фабрик ГмбХ |
Фторалкоксизамещенные бензамиды, способ их получения и фармацевтическая композиция на их основе
|
HUT74170A
(en)
|
1993-07-06 |
1996-11-28 |
Pfizer |
Bicyclic tetrahydro pyrazolopyridines
|
US5362727A
(en)
|
1993-07-26 |
1994-11-08 |
Bristol-Myers Squibb |
Substituted azepino[2,1-a]isoquinoline compounds
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
JP3775685B2
(ja)
|
1993-07-28 |
2006-05-17 |
ローン−プーラン・ロレ・リミテツド |
Pde▲iv▼およびtnf抑制剤としての化合物
|
JPH09501420A
(ja)
|
1993-07-30 |
1997-02-10 |
スミスクライン・ビーチャム・コーポレイション |
3−シアノ−3−(3,4−二置換)フェニルシクロヘキシル−1−カルボキシレート類
|
EP0714397A1
(en)
|
1993-08-19 |
1996-06-05 |
Smithkline Beecham Corporation |
Phenethylamine compounds
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
WO1995009624A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation
|
WO1995009836A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Cyanocyclohexane compounds, compositions, and uses thereof
|
WO1995009623A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Anti-allergic, anti-inflammatory compounds, compositions and uses
|
EP0722322B1
(en)
|
1993-10-01 |
2001-11-14 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation therewith
|
WO1995011694A1
(en)
*
|
1993-10-26 |
1995-05-04 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US5879656A
(en)
*
|
1993-10-26 |
1999-03-09 |
Thomas Jefferson University |
Methods of treating metastatic colorectal cancer with ST receptor binding compounds
|
US5601990A
(en)
*
|
1994-09-13 |
1997-02-11 |
Thomas Jefferson University |
Methods of diagnosing colorectal tumors and metastasis thereof
|
US5518888A
(en)
*
|
1993-10-26 |
1996-05-21 |
Thomas Jefferson University |
ST receptor binding compounds and methods of using the same
|
US5489670A
(en)
|
1993-10-29 |
1996-02-06 |
G. D. Searle & Co. |
Human uroguanylin
|
GB9322828D0
(en)
|
1993-11-05 |
1993-12-22 |
Sandoz Ltd |
Organic compounds
|
JP4071823B2
(ja)
|
1993-11-17 |
2008-04-02 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション |
脂肪酸送達システム
|
US5525723A
(en)
|
1993-11-18 |
1996-06-11 |
Bristol-Myers Squibb Co. |
Compounds containing a fused multiple ring lactam
|
DK0730588T3
(da)
|
1993-11-26 |
1997-12-08 |
Pfizer |
Isoxazolinforbindelser som antiinflammatoriske midler
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
WO1995014680A1
(en)
|
1993-11-26 |
1995-06-01 |
Pfizer Inc. |
3-aryl-2-isoxazolines as antiinflammatory agents
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
DE69433594T2
(de)
|
1993-12-22 |
2004-08-05 |
Celltech R&D Ltd., Slough |
Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
|
US5508300A
(en)
|
1994-01-14 |
1996-04-16 |
Pfizer Inc. |
Dihydro pyrazolopyrroles, compositions and use
|
JP2928079B2
(ja)
|
1994-02-14 |
1999-07-28 |
永信薬品工業股▲ふん▼有限公司 |
1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
|
JPH09510191A
(ja)
|
1994-02-17 |
1997-10-14 |
アメリカン・ホーム・プロダクツ・コーポレイション |
ホスホジエステラーゼ阻害薬としての置換ビフェニル誘導体
|
CA2143143A1
(en)
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
GB9404706D0
(en)
|
1994-03-11 |
1994-04-27 |
Smithkline Beecham Corp |
Compounds
|
US5952314A
(en)
|
1994-04-01 |
1999-09-14 |
Demichele; Stephen Joseph |
Nutritional product for a person having ulcerative colitis
|
WO1995027692A1
(en)
|
1994-04-08 |
1995-10-19 |
Smithkline Beecham Corporation |
Subtituted biphenyl tnf inhibitors
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
CA2188269A1
(en)
|
1994-04-21 |
1995-11-02 |
Helmut Wachtel |
Pde iv inhibitors for treating multiple sclerosis
|
DE69528583T2
(de)
|
1994-04-22 |
2003-07-10 |
Yamanouchi Pharma Co Ltd |
Kolon-spezifisches arzneistofffreisetzungssystem
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
ATE175667T1
(de)
|
1994-05-31 |
1999-01-15 |
Bayer Ag |
Aminobenzofuryl- und -thienylderivate
|
HRP950288A2
(en)
|
1994-05-31 |
1997-08-31 |
Bayer Ag |
Oxalylamino-benzofuran- and benzothienyl-derivatives
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
GB9412383D0
(en)
|
1994-06-21 |
1994-08-10 |
Celltech Ltd |
Chemical compound
|
CA2193725A1
(en)
|
1994-06-24 |
1996-01-04 |
David Cavalla |
Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
JP4146894B2
(ja)
|
1994-07-22 |
2008-09-10 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジヒドロベンゾフラン
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
US5491134A
(en)
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
SK45497A3
(en)
|
1994-10-12 |
1997-10-08 |
Euro Celtique Sa |
Benzoxazoles, pharmaceutical composition containing them and their use
|
PL321136A1
(en)
|
1994-11-07 |
1997-11-24 |
Pfizer |
Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
US5902726A
(en)
|
1994-12-23 |
1999-05-11 |
Glaxo Wellcome Inc. |
Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
|
US5843866A
(en)
|
1994-12-30 |
1998-12-01 |
Hampshire Chemical Corp. |
Pesticidal compositions comprising solutions of polyurea and/or polyurethane
|
DE19501481A1
(de)
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
WO1996023515A1
(en)
|
1995-01-31 |
1996-08-08 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
CA2211656A1
(en)
|
1995-01-31 |
1996-08-08 |
Margret B. Basinski |
Anti-obesity proteins
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
US5612052A
(en)
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
DK0835126T3
(da)
|
1995-06-27 |
2003-07-14 |
Elan Pharm Inc |
Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser
|
US5877224A
(en)
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
EP0788353A1
(en)
|
1995-09-18 |
1997-08-13 |
Ligand Pharmaceuticals, Inc. |
Ppar gamma antagonists for treating obesity
|
AUPN634595A0
(en)
|
1995-11-03 |
1995-11-30 |
Borody, Thomas Julius |
Improved method for colonic evacuation
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
SK66798A3
(en)
|
1995-11-24 |
1999-01-11 |
Smithkline Beecham Spa |
Quinoline derivative, preparation method thereof, pharmaceutical composition containing the same and its use
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
WO1997020821A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl derivatives
|
AU7692896A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Quinazolin-2,4-diazirines as NPY receptor antagonist
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
ATE344279T1
(de)
|
1995-12-13 |
2006-11-15 |
Univ California |
Kristalle der mit einem ligand komplexierten ligandenbindedomäne des schilddrüsenhormonrezeptors
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
CA2244831A1
(en)
|
1996-02-02 |
1997-08-07 |
John T. Olson |
Method of treating diabetes and related disease states
|
CA2245529A1
(en)
|
1996-02-02 |
1997-08-07 |
Soumya P. Sahoo |
Antidiabetic agents
|
ATE262334T1
(de)
|
1996-02-02 |
2004-04-15 |
Merck & Co Inc |
Antidiabetisches mittel
|
CA2245586A1
(en)
|
1996-02-06 |
1997-08-14 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
JP3155013B2
(ja)
|
1996-04-23 |
2001-04-09 |
キナートン・リミテッド |
酸性ポリ乳酸ポリマー
|
WO1997046556A1
(en)
|
1996-06-07 |
1997-12-11 |
Merck & Co., Inc. |
OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
|
EP0930882A2
(en)
|
1996-08-02 |
1999-07-28 |
Institut Pasteur De Lille |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
US5861398A
(en)
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
AU717633B2
(en)
|
1996-09-09 |
2000-03-30 |
Kiwitech Limited |
Acid casein or a non-toxic soluble salt thereof and high-methoxyl pectin polymer
|
AU4176997A
(en)
|
1996-09-16 |
1998-04-02 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
HRP970493A2
(en)
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
DE69729315T2
(de)
|
1996-12-16 |
2005-06-23 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
EP0971588B1
(en)
|
1997-01-21 |
2004-03-17 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor modulators
|
ID22273A
(id)
|
1997-01-28 |
1999-09-23 |
Merck & Co Inc |
TIAZOL BENZENASULFONAMIDA SEBAGAI AGONIS β UNTUK PENGOBATAN DIABETES DAN OBESITAS
|
CN1246845A
(zh)
|
1997-02-04 |
2000-03-08 |
纳幕尔杜邦公司 |
杀菌的羧酰胺
|
US6589750B2
(en)
|
1997-02-20 |
2003-07-08 |
Institut Pasteur |
Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
|
KR100586349B1
(ko)
|
1997-02-21 |
2006-06-08 |
바이엘 악티엔게젤샤프트 |
아릴술폰아미드 및 그의 유사체, 및 신경 변성 질병 치료에있어서 그의 용도
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
US5893985A
(en)
|
1997-03-14 |
1999-04-13 |
The Lincoln Electric Company |
Plasma arc torch
|
EP0979228A4
(en)
|
1997-03-18 |
2000-05-03 |
Smithkline Beecham Corp |
CANNABINOID RECEPTOR AGONISTS
|
JPH10324642A
(ja)
|
1997-03-26 |
1998-12-08 |
Meiji Seika Kaisha Ltd |
大腸送達性構造体
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
US6258837B1
(en)
|
1997-04-23 |
2001-07-10 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptide Y receptor antagonist
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
AU735760B2
(en)
|
1997-04-24 |
2001-07-12 |
Merck Sharp & Dohme Limited |
Use of a NK-1 receptor antagonist and an SSRI for treating obesity
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
DE59811840D1
(de)
|
1997-09-12 |
2004-09-23 |
Pharis Biotec Gmbh |
Zusammensetzung zur therapie von diabetes mellitus und fettsucht
|
DE19744027A1
(de)
|
1997-10-06 |
1999-04-08 |
Hoechst Marion Roussel De Gmbh |
Substituierte Pyrazolo[3,4-b]pyridine, ihre Herstellung und Verwendung in Arzneimitteln
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
EP1124807A1
(en)
|
1997-10-27 |
2001-08-22 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
US6203513B1
(en)
|
1997-11-20 |
2001-03-20 |
Optonol Ltd. |
Flow regulating implant, method of manufacture, and delivery device
|
WO1999038850A1
(en)
|
1998-01-29 |
1999-08-05 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
EP2823812A1
(en)
|
1998-02-02 |
2015-01-14 |
Trustees Of Tufts College |
Dipeptidylpeptidase IV inhibitors for use in the treatment of Type II diabetes
|
WO1999046272A1
(en)
|
1998-03-09 |
1999-09-16 |
Fondatech Benelux N.V. |
Serine peptidase modulators
|
AU3464599A
(en)
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
AU759313B2
(en)
|
1998-04-29 |
2003-04-10 |
Ortho-Mcneil Pharmaceutical, Inc. |
N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
CN1308627A
(zh)
|
1998-05-12 |
2001-08-15 |
美国家用产品公司 |
可用于治疗胰岛素抗性和高血糖的11-芳基-苯并[b]萘并[2,3-d]呋喃和11-芳基-苯并[b]萘并[2,3-d]噻吩
|
IL139132A0
(en)
|
1998-05-12 |
2001-11-25 |
American Home Prod |
Benzothiophenes, benzofurans and indoles useful in the treatment of insulin resistance and hyperglycemia
|
CA2330557A1
(en)
|
1998-05-12 |
1999-11-18 |
Robert Emmett Mcdevitt |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
WO1999058522A1
(en)
|
1998-05-12 |
1999-11-18 |
American Home Products Corporation |
Naphtho[2,3-b]heteroar-4-yl derivatives
|
JP2002507543A
(ja)
|
1998-05-27 |
2002-03-12 |
ドクター・レディーズ・リサーチ・ファウンデーション |
二環系化合物、その製造方法およびそれらを含有する薬学的組成物
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
CA2334551A1
(en)
|
1998-06-11 |
1999-12-16 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19830375A1
(de)
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
ATE302274T1
(de)
|
1998-09-10 |
2005-09-15 |
Millennium Pharm Inc |
Methoden zur bestimmung von komponenten zur modulation des körpergewichts
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
ATE457169T1
(de)
|
1998-10-15 |
2010-02-15 |
Imp Innovations Ltd |
Verbindungen für die behandlung von gewichtsverlust
|
WO2000023445A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
WO2000023417A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
EP1123267A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
CA2350714A1
(en)
|
1998-11-10 |
2000-05-18 |
Merck & Co., Inc. |
Spiro-indolines as y5 receptor antagonists
|
US6235782B1
(en)
*
|
1998-11-12 |
2001-05-22 |
Rifat Pamukcu |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
|
IT1304152B1
(it)
|
1998-12-10 |
2001-03-08 |
Mediolanum Farmaceutici Srl |
Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
DE19903087A1
(de)
*
|
1999-01-27 |
2000-08-10 |
Forssmann Wolf Georg |
Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
PL351963A1
(en)
|
1999-03-19 |
2003-07-14 |
Knoll Gmbh |
Method of treating eating disorders
|
JP4928668B2
(ja)
|
1999-03-31 |
2012-05-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
制御放出製剤中の前糊化澱粉
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6218408B1
(en)
|
1999-06-30 |
2001-04-17 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
EP1816127A1
(en)
|
1999-04-22 |
2007-08-08 |
H. Lundbeck A/S |
Triazine derivatives for use as selective npy (y5) antagonists
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
EP1177172A1
(en)
|
1999-05-05 |
2002-02-06 |
Ortho-McNeil Pharmaceutical, Inc. |
3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
|
AU778393B2
(en)
|
1999-05-12 |
2004-12-02 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyrazole carboxamides useful for the treatment of obesity and other disorders
|
WO2000074679A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
GB9913782D0
(en)
|
1999-06-14 |
1999-08-11 |
Smithkline Beecham Plc |
Novel compounds
|
CA2373920A1
(en)
|
1999-06-15 |
2000-12-21 |
Wei Deng |
Substituted heterocycle fused gamma-carbolines
|
US6207699B1
(en)
|
1999-06-18 |
2001-03-27 |
Richard Brian Rothman |
Pharmaceutical combinations for treating obesity and food craving
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
DK1185294T3
(da)
|
1999-06-23 |
2005-08-01 |
Centre Nat Rech Scient |
Peptider til behandling af svækkede interpersonelle og adfærdsmæssige lidelser
|
WO2001001964A2
(en)
|
1999-06-23 |
2001-01-11 |
Sedum Laboratories, Inc. |
Ionically formulated biomolecule microcarriers
|
SG148834A1
(en)
|
1999-06-30 |
2009-01-29 |
Japan Tobacco Inc |
Compounds for the modulation of ppary activity
|
WO2001002379A1
(en)
|
1999-06-30 |
2001-01-11 |
Synaptic Pharmaceutical Corporation |
Selective npy (y5) antagonists
|
AU6000900A
(en)
|
1999-07-23 |
2001-02-13 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
EP1493742A1
(en)
|
1999-07-28 |
2005-01-05 |
Ortho-Mcneil Pharmaceutical, Inc. |
Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
HUP0203060A3
(en)
|
1999-08-18 |
2003-11-28 |
Sod Conseils Rech Applic |
Sustained release complex of a peptide, process for its preparation and pharmaceutical composition containing the same
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
CA2381111A1
(en)
|
1999-08-26 |
2001-03-01 |
Leah M. Giupponi |
Npy antagonists: spiroisoquinolinone derivatives
|
EP1227134B1
(en)
|
1999-08-31 |
2006-10-04 |
Daikin Industries, Ltd. |
Polymer composition crosslinkable with ultraviolet
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
WO2001021169A1
(fr)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Antagonistes de l'hormone de concentration de la melanine
|
DE60026155T2
(de)
|
1999-09-30 |
2006-08-10 |
Neurogen Corp., Branford |
Einige alkylendiamin-substituierte heterocyclen
|
CN1377355A
(zh)
|
1999-09-30 |
2002-10-30 |
纽罗杰有限公司 |
氨基取代的吡唑并[1,5-a]-1,5-嘧啶和吡唑并[1,5-a]-1,3,5-三嗪
|
CN1377354A
(zh)
|
1999-09-30 |
2002-10-30 |
纽罗杰有限公司 |
某些亚烷基二胺一取代的吡唑并[1,5-a]-1,5-嘧啶和吡唑并[1,5-a]-1,3,5-三嗪
|
WO2001025192A1
(en)
|
1999-10-06 |
2001-04-12 |
Melacure Therapeutics Ab |
Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
|
JP2003516316A
(ja)
|
1999-10-06 |
2003-05-13 |
ファルマシア コーポレイション |
腸癌阻止剤としてのウログアニリン
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
BR0014733A
(pt)
|
1999-10-13 |
2002-06-11 |
Pfizer Prod Inc |
Derivados éter biarìlico úteis como inibidores de recaptação de monoamina
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
ATE275402T1
(de)
|
1999-11-01 |
2004-09-15 |
John Rhodes |
Arzneimittel zur behandlung von darmverstopfung und reizkolon
|
JP2003524632A
(ja)
|
1999-11-05 |
2003-08-19 |
アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
インデノ−、ナフト−、及びベンゾシクロヘプタ−ジヒドロチアゾール誘導体、それらの製造及びそれらの食欲抑制薬としての使用
|
DE60022386T2
(de)
|
1999-12-16 |
2006-06-22 |
Schering Corp. |
Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
|
FR2802817B1
(fr)
|
1999-12-23 |
2002-10-11 |
Centre Nat Rech Scient |
Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
|
US7521061B2
(en)
|
1999-12-31 |
2009-04-21 |
Rutgers, The State University Of New Jersey |
Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
|
WO2001049311A1
(en)
|
1999-12-31 |
2001-07-12 |
Rutgers, The State University |
Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
|
EP1263453A4
(en)
|
1999-12-31 |
2008-02-20 |
Univ Rutgers |
PHARMACEUTICAL FORMULATION CONSISTING OF A POLYMERMATRIX, FOR REGULATING THE TIME-CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES
|
US20030064105A1
(en)
|
2000-08-25 |
2003-04-03 |
Myung-Jin Kim |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
AU2001214778A1
(en)
|
2000-01-26 |
2001-08-07 |
Warner Lambert Company |
Method for preventing or treating postoperative ileus
|
WO2001056592A1
(en)
|
2000-02-01 |
2001-08-09 |
Novo Nordisk A/S |
Use of compounds for the regulation of food intake
|
AU2001234958A1
(en)
|
2000-02-11 |
2001-08-20 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
US7064142B2
(en)
|
2000-02-22 |
2006-06-20 |
Banyu Pharmaceutical, Co., Ltd. |
Imidazonline compounds
|
ES2231482T3
(es)
|
2000-02-23 |
2005-05-16 |
Aventis Pharma Deutschland Gmbh |
Derivados de 8,8a-dihidro-indeno(1,2-d)tiazol, sustituidos en posicion 8a, procedimiento para su preparacion y su uso como medicamentos, por ejemplo como anorexicos.
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
EE04963B1
(et)
|
2000-02-26 |
2008-02-15 |
Aventis Pharma Deutschland Gmbh |
8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena
|
WO2001064212A1
(en)
|
2000-03-01 |
2001-09-07 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
PT1274687E
(pt)
|
2000-03-14 |
2005-04-29 |
Actelion Pharmaceuticals Ltd |
Derivados de 1,2,3,4-tetra-hidroisoquinolina
|
EP1268000A4
(en)
|
2000-03-23 |
2004-12-29 |
Merck & Co Inc |
SPIROPIPERID DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS
|
RU2245878C2
(ru)
|
2000-03-23 |
2005-02-10 |
Солвей Фармасьютикалс Б.В. |
Производные 4,5-дигидро-1н-пиразола, обладающие cb1-антагонистической активностью
|
AU4929601A
(en)
|
2000-03-23 |
2001-10-03 |
Merck & Co Inc |
Substituted piperidines as melanocortin receptor agonists
|
PH12001000675B1
(en)
|
2000-04-04 |
2009-09-22 |
Australian Food Ind Sci Ct |
Encapsulation of food ingredients
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
WO2001076632A1
(en)
|
2000-04-10 |
2001-10-18 |
Wald Nicholas J |
Formulation for the prevention of cardiovascular disease
|
WO2001079150A1
(en)
|
2000-04-17 |
2001-10-25 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
EP1365806A2
(en)
|
2000-04-19 |
2003-12-03 |
Johns Hopkins University |
Use of no acttivators for treatment and prevention of gastrointestinal disorders
|
CA2407149C
(en)
|
2000-04-28 |
2010-10-12 |
Takeda Chemical Industries, Ltd. |
Melanin-concentrating hormone antagonist
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
AU2001263021A1
(en)
|
2000-05-10 |
2001-11-20 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
MXPA02010452A
(es)
|
2000-05-11 |
2003-06-06 |
Bristol Myers Squibb Co |
Analogos de tetrahidroisoquinolina utiles como secretagogos de la hormona del crecimiento.
|
US7229986B2
(en)
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
EP1286697A2
(en)
|
2000-05-17 |
2003-03-05 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
WO2001091752A1
(en)
|
2000-05-30 |
2001-12-06 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
BR0111991A
(pt)
|
2000-06-15 |
2003-04-01 |
Schering Corp |
Antagonistas de receptor de trombina
|
AU2001272476A1
(en)
|
2000-06-16 |
2001-12-24 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
MXPA03000174A
(es)
|
2000-07-06 |
2003-09-22 |
Neurogen Corp |
Ligandos de receptor de hormona concentradora de melanina.
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
CZ2003106A3
(cs)
|
2000-07-13 |
2003-04-16 |
Eli Lilly And Company |
Agonisté adrenergního beta-3 receptoru
|
KR20030033002A
(ko)
|
2000-07-24 |
2003-04-26 |
아다나 바이오싸이언스 리미티드 |
그렐린 길항제
|
ATE305933T1
(de)
|
2000-07-31 |
2005-10-15 |
Hoffmann La Roche |
Piperazin derivate
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
WO2002015905A1
(en)
|
2000-08-21 |
2002-02-28 |
Gliatech, Inc. |
The use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
|
WO2002015845A2
(en)
|
2000-08-21 |
2002-02-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
JP2004506687A
(ja)
|
2000-08-23 |
2004-03-04 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作働薬としての置換ピペリジン類
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
EP1322628A2
(en)
|
2000-09-14 |
2003-07-02 |
Schering Corporation |
Substituted urea neuropeptide y y5 receptor antagonists
|
WO2002026743A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
AU2001292518A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel compounds
|
JP2002114768A
(ja)
|
2000-10-11 |
2002-04-16 |
Japan Tobacco Inc |
2−(2,5−ジハロゲン−3,4−ジヒドロキシフェニル)アゾール化合物及びそれを含有してなる医薬組成物
|
KR20030042014A
(ko)
|
2000-10-13 |
2003-05-27 |
일라이 릴리 앤드 캄파니 |
성장호르몬 분비촉진제로서 치환된 디펩티드
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
DE60135239D1
(de)
|
2000-10-16 |
2008-09-18 |
Vernalis Res Ltd |
Indolinderivate und deren verwendung als 5-ht2 rezeptor liganden
|
MXPA03003455A
(es)
|
2000-10-20 |
2003-07-14 |
Pfizer Prod Inc |
Agonistas del receptor beta3-adrenergico y usos de los mismos.
|
WO2002036596A2
(en)
|
2000-11-03 |
2002-05-10 |
Wyeth |
CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
|
AU2002230778A1
(en)
|
2000-11-03 |
2002-05-15 |
The Regents Of The University Of California |
Prokineticin polypeptides, related compositions and methods
|
DE10055857A1
(de)
|
2000-11-10 |
2002-08-22 |
Creative Peptides Sweden Ab Dj |
Neue pharmazeutische Depotformulierung
|
JP2004513164A
(ja)
|
2000-11-10 |
2004-04-30 |
イーライ・リリー・アンド・カンパニー |
3−置換オキシインドールβ3アゴニスト
|
EP1337518B1
(en)
|
2000-11-20 |
2009-06-17 |
Biovitrum AB (publ) |
Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
|
AU2002224266B2
(en)
|
2000-11-20 |
2007-05-24 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
|
ATE286897T1
(de)
|
2000-11-28 |
2005-01-15 |
Smithkline Beecham Plc |
Morpholinderivate als antagonisten an orexinrezeptoren
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
US20050033048A1
(en)
|
2000-12-12 |
2005-02-10 |
Rajagopal Bakthavatchalam |
Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
|
EP1349563B1
(en)
|
2000-12-14 |
2009-12-02 |
Amylin Pharmaceuticals, Inc. |
Peptide pyy[3-36] for treatment of metabolic disorders
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
IL156157A0
(en)
|
2000-12-21 |
2003-12-23 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
DK1216707T3
(da)
|
2000-12-22 |
2005-05-09 |
Pasteur Institut |
Fremgangsmåde til screening af ligandmolekyler, der specifikt binder til NEP-bindingsstederne for QHNPR-pentapeptidet
|
CN1531527A
(zh)
|
2000-12-22 |
2004-09-22 |
|
咔唑衍生物及其作为神经肽y5受体配体的用途
|
ES2243588T3
(es)
|
2000-12-22 |
2005-12-01 |
Schering Corporation |
Antagonistas piperidinicos de la mch y su uso en el tratamientyo de la obesidad.
|
JP4088412B2
(ja)
*
|
2000-12-26 |
2008-05-21 |
トヨタ自動車株式会社 |
内燃機関の空燃比制御装置
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
WO2002051844A1
(en)
|
2000-12-27 |
2002-07-04 |
F. Hoffmann-La Roche Ag |
Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
|
EP1368339A1
(en)
|
2001-01-23 |
2003-12-10 |
Eli Lilly & Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
WO2002059117A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
|
EP1358163A1
(en)
|
2001-01-23 |
2003-11-05 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
EP2039357A2
(en)
|
2001-01-26 |
2009-03-25 |
Schering Corporation |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
CA2435415A1
(en)
|
2001-01-26 |
2002-08-01 |
Debio Recherche Pharmaceutique S.A. |
Microparticles of biodegradable polymer encapsulating a biologically active substance
|
MXPA03006936A
(es)
|
2001-02-02 |
2003-11-18 |
Pfizer |
Tratamiento de diabetes mellitus.
|
JP2004521123A
(ja)
|
2001-02-02 |
2004-07-15 |
ファルマシア・コーポレーション |
腸癌阻害のためのウログアニリンおよびシクロオキシゲナーゼ−2阻害薬の組合わせ
|
BR0206831A
(pt)
|
2001-02-02 |
2004-07-06 |
Takeda Chemical Industries Ltd |
Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto
|
EP1363914A1
(en)
|
2001-02-05 |
2003-11-26 |
Dr. Reddy's Laboratories Ltd. |
Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
|
DE60232238D1
(de)
|
2001-02-28 |
2009-06-18 |
Merck & Co Inc |
Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
|
DE60219295T2
(de)
|
2001-02-28 |
2008-01-03 |
Merck & Co., Inc. |
Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
|
ES2272703T3
(es)
|
2001-02-28 |
2007-05-01 |
MERCK & CO., INC. |
Derivados de piperidina acilados como agonistas de receptor de melanocortina-4.
|
DE60211495T2
(de)
|
2001-02-28 |
2006-12-14 |
Smithkline Beecham Corp. |
Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
GB0105772D0
(en)
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
CN1499960A
(zh)
|
2001-03-13 |
2004-05-26 |
����˹��ҩ�﹫˾ |
时间治疗剂型
|
CA2540761A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Glaukos Corporation |
Applicator and methods for placing a trabecular shunt for glaucoma treatment
|
EP1383376A4
(en)
|
2001-03-19 |
2006-03-08 |
Praecis Pharm Inc |
PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
EP1370520A1
(en)
|
2001-03-21 |
2003-12-17 |
Pharmacopeia, Inc. |
Aryl and biaryl compounds having mch modulatory activity
|
HUP0303148A3
(en)
|
2001-03-22 |
2009-08-28 |
Solvay Pharm Bv |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
|
WO2001074782A1
(en)
|
2001-03-29 |
2001-10-11 |
Molecular Design International, Inc. |
β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
|
EA006651B1
(ru)
*
|
2001-03-29 |
2006-02-24 |
Синерджи Фармасьютикалз, Инк. |
Агонисты гуанилатциклазного рецептора для лечения тканевого воспаления и канцерогенеза
|
GB0108631D0
(en)
|
2001-04-05 |
2001-05-30 |
Melacure Therapeutics Ab |
Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
|
US7431710B2
(en)
*
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
PE20021081A1
(es)
|
2001-04-12 |
2002-12-18 |
Pharmacopeia Drug Discovery |
Aril y biaril piperidinas con actividad moduladora mch
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
DK2322631T3
(en)
|
2001-04-19 |
2015-01-12 |
Scripps Research Inst |
Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar
|
DE60225127T2
(de)
|
2001-04-30 |
2009-02-19 |
Glaxo Group Ltd., Greenford |
Kondensierte pyrimidine als antagonisten des corticotropin releasing factor (crf)
|
KR20030096348A
(ko)
|
2001-05-05 |
2003-12-24 |
스미스클라인비이참피이엘시이 |
N-아로일 시클릭 아민
|
EP1435955A2
(en)
|
2001-05-05 |
2004-07-14 |
SmithKline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
ATE387428T1
(de)
|
2001-05-21 |
2008-03-15 |
Hoffmann La Roche |
Chinolinderivate als liganden für den neuropeptid-y-rezeptor
|
JP2004530702A
(ja)
|
2001-05-21 |
2004-10-07 |
ニューロクライン バイオサイエンシーズ, インコーポレイテッド |
Crf受容体アンタゴニストとしてのトリ−およびテトラアザ−アセナフチレン誘導体
|
BR0209932A
(pt)
|
2001-05-22 |
2004-10-13 |
Neurogen Corp |
Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
|
AU2002316771A1
(en)
|
2001-06-05 |
2002-12-16 |
Yalcin Cetin |
Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
|
EP1406872B1
(en)
|
2001-06-20 |
2007-12-19 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
WO2003000685A1
(en)
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
5-membered heterocycle derivatives
|
ES2257555T3
(es)
|
2001-06-20 |
2006-08-01 |
MERCK & CO., INC. |
Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes.
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
ZA200301312B
(en)
|
2001-06-27 |
2004-03-30 |
Probiodrug Ag |
Peptide structures useful for competitive modulation of dipertidyl peptidase IV catalysis.
|
ATE374181T1
(de)
|
2001-06-27 |
2007-10-15 |
Smithkline Beecham Corp |
Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren
|
JP4357293B2
(ja)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
DE60223920T2
(de)
|
2001-06-27 |
2008-11-13 |
Smithkline Beecham Corp. |
Pyrrolidine als dipeptidyl-peptidase-inhibitoren
|
JP2003018009A
(ja)
|
2001-06-29 |
2003-01-17 |
Mitsubishi Electric Corp |
デジタルアナログコンバータ
|
WO2003004458A1
(en)
|
2001-07-03 |
2003-01-16 |
Biovitrum Ab |
New compounds
|
EP1404675B1
(en)
|
2001-07-03 |
2008-03-12 |
Novo Nordisk A/S |
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
|
EA005934B1
(ru)
|
2001-07-05 |
2005-08-25 |
Х. Лундбекк А/С |
Замещённые анилиновые пиперидины в качестве селективных антагонистов мсн
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
ITMI20011483A1
(it)
|
2001-07-11 |
2003-01-11 |
Res & Innovation Soc Coop A R |
Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi
|
CA2453027A1
(en)
|
2001-07-12 |
2003-01-23 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
GB0117396D0
(en)
|
2001-07-17 |
2001-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
EP1411940B1
(en)
|
2001-07-18 |
2008-10-15 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
WO2003007887A2
(en)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
AU2002319653A1
(en)
|
2001-07-20 |
2003-03-03 |
Samir Mitragotri |
Method for oral drug delivery
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
IL159643A0
(en)
|
2001-07-26 |
2004-06-01 |
Schering Corp |
Substituted urea neuropeptide y y5 receptor antagonists
|
WO2003011267A1
(fr)
|
2001-07-31 |
2003-02-13 |
The Nisshin Oillio, Ltd. |
Medicaments anti-obesite et ses substances
|
WO2003014113A1
(en)
|
2001-08-06 |
2003-02-20 |
Glenmark Pharmaceuticals Limited |
Novel benzopyran compounds and process for their preparation and use
|
GB0119172D0
(en)
|
2001-08-06 |
2001-09-26 |
Melacure Therapeutics Ab |
Phenyl pyrrole derivatives
|
WO2003014083A1
(fr)
|
2001-08-07 |
2003-02-20 |
Banyu Pharmaceutical Co., Ltd. |
Composes spiro
|
JP2004537581A
(ja)
|
2001-08-08 |
2004-12-16 |
メルク エンド カムパニー インコーポレーテッド |
メラニン濃縮ホルモン拮抗物質
|
EP1444224B1
(en)
|
2001-08-14 |
2006-05-03 |
Eli Lilly And Company |
3-substituted oxindole beta-3 agonists
|
ATE340794T1
(de)
|
2001-08-14 |
2006-10-15 |
Lilly Co Eli |
Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
|
WO2003016265A1
(fr)
|
2001-08-17 |
2003-02-27 |
Eisai Co., Ltd. |
Compose cyclique et agoniste du recepteur ppar
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20040198774A1
(en)
|
2001-08-23 |
2004-10-07 |
Shinichi Ishii |
Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
|
US20030092041A1
(en)
|
2001-08-23 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
|
WO2004019872A2
(en)
|
2002-08-30 |
2004-03-11 |
Biorexis Pharmaceutical Corporation |
Oral delivery of modified transferrin fusion proteins
|
JP2005507875A
(ja)
|
2001-08-31 |
2005-03-24 |
ユニバーシティ オブ コネチカット |
カンナビノイド受容体に作用する新規なピラゾール類似体
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
EP1426370A4
(en)
|
2001-09-13 |
2009-12-23 |
Nisshin Pharma Inc |
PROPANOLAMINE DERIVATIVE WITH 1,4-BENZODIOXANE CORE
|
EP1430027B1
(en)
|
2001-09-14 |
2010-09-01 |
High Point Pharmaceuticals, LLC |
Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
|
US20040259883A1
(en)
|
2001-09-14 |
2004-12-23 |
Hiroshi Sakashita |
Thiazolidine derivative and medicinal use thereof
|
DE60234616D1
(de)
|
2001-09-14 |
2010-01-14 |
High Point Pharmaceuticals Llc |
Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
|
EP1430043A1
(en)
|
2001-09-14 |
2004-06-23 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
JP2005509603A
(ja)
|
2001-09-19 |
2005-04-14 |
ノボ ノルディスク アクティーゼルスカブ |
Dpp−iv酵素の阻害剤であるヘテロ環化合物
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
MXPA04002583A
(es)
|
2001-09-21 |
2004-06-18 |
Solvay Pharm Bv |
Derivados de 4,5-dihidro-1h-pirazol novedosos que tienen actividad antagonistica del canabinoide (cb1).
|
NZ528280A
(en)
|
2001-09-21 |
2005-11-25 |
Solvay Pharmaceuticals B |
4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
CA2461454A1
(en)
|
2001-09-24 |
2003-04-03 |
Oregon Health And Science University |
Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
UY27450A1
(es)
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
CA2461142A1
(en)
|
2001-09-24 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
|
AU2002331898A1
(en)
|
2001-09-24 |
2003-04-07 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Induction of brown adipocytes by transcription factor nfe2l2
|
BR0212985A
(pt)
|
2001-09-24 |
2005-08-30 |
Imp College Innovations Ltd |
Uso de pyy ou de um agonista do mesmo na preparação de medicamentos para tratamento de distúrbios associados com excesso de peso
|
US20040191926A1
(en)
|
2001-09-26 |
2004-09-30 |
Zhong-Yin Zhang |
Ptp1b inhibitors and ligands
|
PL369567A1
(en)
|
2001-09-26 |
2005-05-02 |
Bayer Pharmaceuticals Corporation |
1,6-naphthyridine derivatives as antidiabetics
|
US6787558B2
(en)
|
2001-09-28 |
2004-09-07 |
Hoffmann-La Roche Inc. |
Quinoline derivatives
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
US7253190B2
(en)
|
2001-10-04 |
2007-08-07 |
Merck & Co., Inc. |
Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5
|
WO2003031439A1
(en)
|
2001-10-05 |
2003-04-17 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
JP2005506338A
(ja)
|
2001-10-09 |
2005-03-03 |
ニューロクライン バイオサイエンシーズ, インコーポレイテッド |
メラノコルチンレセプターのリガンドならびに関連の配合物および方法
|
WO2003030901A1
(en)
|
2001-10-09 |
2003-04-17 |
Pharmacia & Upjohn Company |
Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US20050014805A1
(en)
|
2001-10-12 |
2005-01-20 |
Chenzhi Zhang |
Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
|
US6573396B2
(en)
|
2001-10-12 |
2003-06-03 |
Exxonmobil Chemical Patents Inc. |
Co-production of dialkyl carbonates and diols with treatment of hydroxy alkyl carbonate
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
IL161431A0
(en)
|
2001-10-16 |
2004-09-27 |
Reddys Lab Ltd Dr |
beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
|
CA2463724A1
(en)
|
2001-10-16 |
2003-04-24 |
Structural Bioinformatics Inc. |
Organosulfur inhibitors of tyrosine phosphatases
|
EP1438283A1
(en)
|
2001-10-17 |
2004-07-21 |
Novo Nordisk A/S |
Dicarboxylic acid derivatives, their preparation and therapeutic use
|
US7022730B2
(en)
|
2001-10-19 |
2006-04-04 |
Transtech Pharma, Inc. |
Bis-heteroaryl alkanes as therapeutic agents
|
WO2003035061A1
(en)
|
2001-10-23 |
2003-05-01 |
Biovitrum Ab |
Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
|
WO2003035602A1
(fr)
|
2001-10-25 |
2003-05-01 |
Sankyo Company, Limited |
Modulateurs lipidiques
|
IL161478A0
(en)
|
2001-10-25 |
2004-09-27 |
Takeda Chemical Industries Ltd |
Quinoline compound
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
US7342117B2
(en)
|
2001-10-30 |
2008-03-11 |
Astellas Pharma Inc. |
α-form or β-form crystal of acetanilide derivative
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
ATE429916T1
(de)
|
2001-11-09 |
2009-05-15 |
Biovitrum Ab Publ |
Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
|
TW200303742A
(en)
|
2001-11-21 |
2003-09-16 |
Novartis Ag |
Organic compounds
|
JP2005517643A
(ja)
|
2001-11-30 |
2005-06-16 |
イーライ・リリー・アンド・カンパニー |
ペルオキシソーム増殖因子活性化受容体アゴニスト
|
JP2005514382A
(ja)
|
2001-11-30 |
2005-05-19 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−5モジュレーター
|
ATE335740T1
(de)
|
2001-12-04 |
2006-09-15 |
Hoffmann La Roche |
Ringannelierte pyrazolderivate
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
DE10160409A1
(de)
|
2001-12-10 |
2003-06-18 |
Guenther Beisel |
Verwendung von ionischen und nichtionischen Celluloseethern zur Herstellung eines gelartigen Mittels zur Verhinderung der Resorption von Fetten aus dem Magen-Darm-Trakt
|
US6923992B2
(en)
|
2001-12-17 |
2005-08-02 |
The Chinese University Of Hong Kong |
Active compounds of Bao-Ji-Wan for anti-diarrhea and relieving gastrointestinal symptoms
|
US7569592B2
(en)
|
2001-12-18 |
2009-08-04 |
Merck & Co., Inc. |
Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
|
DE60222698T2
(de)
|
2001-12-18 |
2008-06-19 |
Merck & Co., Inc. |
Heteroarylsubstituierte triazolmodulatoren des metabotropen glutamatarezeptors 5
|
AU2002360621B2
(en)
|
2001-12-19 |
2007-01-25 |
Merck & Co., Inc. |
heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
CA2471096A1
(en)
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
WO2003053976A1
(en)
|
2001-12-20 |
2003-07-03 |
Biovitrum Ab |
PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR
|
AU2002364906B2
(en)
|
2001-12-21 |
2007-08-16 |
Merck & Co., Inc. |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
EP1321142A1
(en)
|
2001-12-21 |
2003-06-25 |
Novartis AG |
Solid pharmaceutical composition for oral administration of Tegaserod
|
FR2833949B1
(fr)
|
2001-12-21 |
2005-08-05 |
Galderma Res & Dev |
NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
US20030129160A1
(en)
|
2002-01-09 |
2003-07-10 |
John-Olov Jansson |
Use of Interleukin-6
|
JP4733922B2
(ja)
|
2002-01-10 |
2011-07-27 |
インペリアル・イノベ−ションズ・リミテッド |
摂食行動の修正
|
KR20040095239A
(ko)
|
2002-02-27 |
2004-11-12 |
화이자 프로덕츠 인코포레이티드 |
Acc 억제제
|
EP1480618B1
(en)
|
2002-03-04 |
2009-06-03 |
Ipsen Pharma |
Sustained release drug formulations containing a carrier peptide
|
ES2399880T3
(es)
|
2002-03-15 |
2013-04-04 |
Cypress Bioscience, Inc. |
Milnaciprán para el tratamiento del síndrome del intestino irritable
|
US20030219479A1
(en)
|
2002-04-08 |
2003-11-27 |
Lavipharm Laboratories Inc. |
Multi-layer mucoadhesive drug delivery device with bursting release layer
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
SE0201175L
(sv)
|
2002-04-18 |
2003-10-19 |
Jonsered Cranes Ab |
Kranarrangemangstillhörig hållarenhet
|
EP2074997A1
(en)
|
2002-05-17 |
2009-07-01 |
Tioga Pharmaceuticals, Inc. |
Use of Asimadoline for the treatment of digestive disorders
|
GB0214013D0
(en)
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
US6991726B2
(en)
*
|
2002-07-01 |
2006-01-31 |
Usfilter Corporation |
Filter having a media retaining plate
|
US7041077B2
(en)
*
|
2002-07-19 |
2006-05-09 |
Yale University |
Uveoscleral drainage device
|
EP1550443A4
(en)
|
2002-09-18 |
2009-04-01 |
Ajinomoto Kk |
COMPOSITION AGAINST STRESS-BASED DISEASES
|
CA2499494A1
(en)
|
2002-09-20 |
2004-04-01 |
Pfizer Inc. |
N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
|
AU2003286836A1
(en)
|
2002-10-31 |
2004-06-07 |
Supergen, Inc. |
Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
|
CN100439341C
(zh)
|
2002-12-02 |
2008-12-03 |
弗·哈夫曼-拉罗切有限公司 |
作为促肾上腺皮质激素释放因子拮抗剂的吲唑衍生物
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
US20040121994A1
(en)
|
2002-12-20 |
2004-06-24 |
Anderson Steven N. |
Novel amides that activate soluble guanylate cyclase
|
JO2696B1
(en)
|
2002-12-23 |
2013-03-03 |
شركة جانسين فارماسوتيكا ان. في |
Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
|
AR042667A1
(es)
|
2002-12-26 |
2005-06-29 |
Taisho Pharmaceutical Co Ltd |
Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
|
WO2004064769A2
(en)
|
2003-01-21 |
2004-08-05 |
Hector Herrera |
Methods for making and using topical delivery agents
|
ATE365174T1
(de)
|
2003-01-28 |
2007-07-15 |
Microbia Inc |
Zusammensetzungen zur behandlung von gastrointestinalen störungen
|
US20060281682A1
(en)
*
|
2003-01-28 |
2006-12-14 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
ZA200409537B
(en)
|
2003-01-31 |
2006-10-25 |
Yamanouchi Pharma Co Ltd |
Stable solid medicinal composition for oral administration
|
US6683072B1
(en)
|
2003-02-04 |
2004-01-27 |
Vela Pharmaceuticals, Inc. |
Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
|
JP2006521810A
(ja)
|
2003-03-11 |
2006-09-28 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための新規組成物と方法
|
WO2004091622A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals, Inc. |
The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
|
CN100372851C
(zh)
|
2003-05-05 |
2008-03-05 |
弗·哈夫曼-拉罗切有限公司 |
具有crf活性的稠合的嘧啶衍生物
|
EP1624875A4
(en)
|
2003-05-16 |
2010-01-20 |
Vela Acquisition Corp |
TREATMENT OF GASTROINTESTINAL DYSFUNCTION AND RELATED LOADS WITH ENANTIOMERIC PURE (R) 2,3-BENZODIAZEPINE
|
US7173010B2
(en)
|
2003-05-19 |
2007-02-06 |
Regents Of The University Of Michigan |
Orphanin FQ receptor
|
US7073363B2
(en)
*
|
2003-05-20 |
2006-07-11 |
Schumag Ag |
Method for processing drawn material and drawn material production installation
|
CA2529307C
(en)
|
2003-06-13 |
2013-12-24 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7494979B2
(en)
*
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
EP1638529B1
(en)
|
2003-06-16 |
2016-08-10 |
ANDRX Pharmaceuticals, LLC. |
Oral extended-release composition
|
DE10331723A1
(de)
|
2003-07-11 |
2005-06-16 |
Merck Patent Gmbh |
Kappa-Agonisten
|
EA200600598A1
(ru)
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
NZ546183A
(en)
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
JP4691500B2
(ja)
|
2003-09-30 |
2011-06-01 |
シャイア エルエルシー |
過剰摂取又は乱用を防止するための薬学組成物
|
US7002015B2
(en)
|
2003-10-14 |
2006-02-21 |
Bristol-Myers Squibb Company |
3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
|
US7291125B2
(en)
*
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
AU2004290456C1
(en)
|
2003-11-21 |
2012-03-15 |
Commonwealth Scientific & Industrial Research Organisation |
G I tract delivery systems
|
WO2005063156A1
(en)
|
2003-12-22 |
2005-07-14 |
Shear/Kershman Laboratories, Inc. |
Oral peptide delivery system with improved bioavailability
|
KR20060123493A
(ko)
|
2003-12-23 |
2006-12-01 |
알자 코포레이션 |
제어된 전달을 위한 약물 조성물의 용해도를 증가시키는방법 및 제형
|
US20050267197A1
(en)
|
2004-05-25 |
2005-12-01 |
Roger Berlin |
Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses
|
WO2006012264A1
(en)
|
2004-06-25 |
2006-02-02 |
Thomas Jefferson University |
Compounds of the inventions of guanylyl cyclase c
|
US20060013889A1
(en)
|
2004-07-16 |
2006-01-19 |
Playford Raymond J |
Colostrum-based treatment for irritable bowel syndrome
|
JP2008507280A
(ja)
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
TWI649790B
(zh)
*
|
2004-11-18 |
2019-02-01 |
日商尼康股份有限公司 |
位置測量方法、位置控制方法、測量方法、裝載方法、曝光方法及曝光裝置、及元件製造方法
|
CA2619650A1
(en)
|
2005-08-19 |
2007-02-22 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20070101158A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Elliott Robert C |
Security region in a non-volatile memory
|
WO2007101158A2
(en)
|
2006-02-24 |
2007-09-07 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7692307B2
(en)
*
|
2006-12-08 |
2010-04-06 |
Intel Corporation |
Compliant structure for an electronic device, method of manufacturing same, and system containing same
|
WO2008106429A2
(en)
|
2007-02-26 |
2008-09-04 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
EP2152266A4
(en)
|
2007-05-04 |
2010-07-28 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS OF TREATING DISORDERS RELATED TO SALT OR LIQUID RETENTION
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
CA2688161C
(en)
|
2007-06-04 |
2020-10-20 |
Kunwar Shailubhai |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
ES2559840T3
(es)
|
2008-06-04 |
2016-02-16 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
JP2011528375A
(ja)
|
2008-07-16 |
2011-11-17 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
EP2373296B1
(en)
|
2008-12-03 |
2016-08-03 |
Synergy Pharmaceuticals Inc. |
Formulations of guanylate cyclase c agonists and methods of use
|
BR112012011730A2
(pt)
|
2009-11-09 |
2016-03-08 |
Ironwood Pharmaceuticals Inc |
tratamentos para distúrbios gastrointestinais
|
US8735360B2
(en)
|
2009-12-07 |
2014-05-27 |
Ironwood Pharmaceuticals, Inc. |
Treatments for gastrointestinal disorders
|
CA2810243C
(en)
|
2010-09-15 |
2021-04-20 |
Synergy Pharmaceuticals Inc. |
Formulations of guanylate cyclase c agonists and methods of use
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
CA2905435A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
CN105764916B
(zh)
*
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|